BACKGROUND: The Framingham equations were developed to predict incident coronary heart disease. It remains unknown how the presence of chronic kidney disease affects their performance. METHODS: Individuals without preexisting cardiovascular disease aged 45 to 74 years from the Atherosclerosis Risk in Communities and Cardiovascular Health Studies were analyzed. Using sex- and race-specific Cox models, we evaluated the 5-year risk of coronary heart disease and mortality events associated with both chronic kidney disease and Framingham risk score, the absolute risk of events caused by kidney disease, and model discrimination. RESULTS: Among 15,717 subjects, 756 (4.8%) had kidney disease. The Framingham risk score independently predicted cardiac and mortality events in all subgroups, whereas kidney disease predicted events in all subgroups except cardiac events in white women. After adjustment for traditional risk factors, the increase in cardiac and mortality events per 1000 person-years attributable to kidney disease was 4.3 and 13.7 for white men, 16.1 and 40.5 for African American men, 1.2 and 5.8 for white women, and 13.6 and 14.2 for African American women, respectively. This represented an additional 17,000 and 12,000 cardiac events and 63,000 and 19,000 deaths per year among whites and African Americans, respectively. Mortality rates attributable to kidney disease, diabetes, and smoking were comparable. Accounting for kidney disease improved discrimination for only mortality outcomes in white men and African American women. CONCLUSIONS: Chronic kidney disease in a community-based population is an important predictor of cardiac and mortality events, particularly in African Americans, but it does not improve discrimination of Framingham equations.
BACKGROUND: The Framingham equations were developed to predict incident coronary heart disease. It remains unknown how the presence of chronic kidney disease affects their performance. METHODS: Individuals without preexisting cardiovascular disease aged 45 to 74 years from the Atherosclerosis Risk in Communities and Cardiovascular Health Studies were analyzed. Using sex- and race-specific Cox models, we evaluated the 5-year risk of coronary heart disease and mortality events associated with both chronic kidney disease and Framingham risk score, the absolute risk of events caused by kidney disease, and model discrimination. RESULTS: Among 15,717 subjects, 756 (4.8%) had kidney disease. The Framingham risk score independently predicted cardiac and mortality events in all subgroups, whereas kidney disease predicted events in all subgroups except cardiac events in white women. After adjustment for traditional risk factors, the increase in cardiac and mortality events per 1000 person-years attributable to kidney disease was 4.3 and 13.7 for white men, 16.1 and 40.5 for African American men, 1.2 and 5.8 for white women, and 13.6 and 14.2 for African American women, respectively. This represented an additional 17,000 and 12,000 cardiac events and 63,000 and 19,000 deaths per year among whites and African Americans, respectively. Mortality rates attributable to kidney disease, diabetes, and smoking were comparable. Accounting for kidney disease improved discrimination for only mortality outcomes in white men and African American women. CONCLUSIONS:Chronic kidney disease in a community-based population is an important predictor of cardiac and mortality events, particularly in African Americans, but it does not improve discrimination of Framingham equations.
Authors: Hiroki Ito; Ivan V Pacold; Ramon Durazo-Arvizu; Kiang Liu; Michael G Shilipak; David C Goff; Russell P Tracy; Holly Kramer Journal: Am J Epidemiol Date: 2011-08-30 Impact factor: 4.897
Authors: Jia Sun; Jonas Axelsson; Anna Machowska; Olof Heimbürger; Peter Bárány; Bengt Lindholm; Karin Lindström; Peter Stenvinkel; Abdul Rashid Qureshi Journal: Clin J Am Soc Nephrol Date: 2016-06-08 Impact factor: 8.237
Authors: Marta Gracia; Àngels Betriu; Montserrat Martínez-Alonso; David Arroyo; María Abajo; Elvira Fernández; José M Valdivielso Journal: Clin J Am Soc Nephrol Date: 2015-12-14 Impact factor: 8.237
Authors: Paul E Drawz; Sarah Baraniuk; Barry R Davis; Clinton D Brown; Pedro J Colon; Aloysius B Cujyet; Richard A Dart; James F Graumlich; Mario A Henriquez; Jamaluddin Moloo; Mohammed G Sakalayen; Debra L Simmons; Carol Stanford; Mary Ellen Sweeney; Nathan D Wong; Mahboob Rahman Journal: Am Heart J Date: 2012-10-29 Impact factor: 4.749
Authors: Konstantinos Tziomalos; Emmanuel S Ganotakis; Irene F Gazi; Devaki R Nair; Dimitri P Mikhailidis Journal: Open Cardiovasc Med J Date: 2009-06-16
Authors: Jane F Ferguson; Gregory J Matthews; Raymond R Townsend; Dominic S Raj; Peter A Kanetsky; Matthew Budoff; Michael J Fischer; Sylvia E Rosas; Radhika Kanthety; Mahboob Rahman; Stephen R Master; Atif Qasim; Mingyao Li; Nehal N Mehta; Haiqing Shen; Braxton D Mitchell; Jeffrey R O'Connell; Alan R Shuldiner; Weang Kee Ho; Robin Young; Asif Rasheed; John Danesh; Jiang He; John W Kusek; Akinlolu O Ojo; John Flack; Alan S Go; Crystal A Gadegbeku; Jackson T Wright; Danish Saleheen; Harold I Feldman; Daniel J Rader; Andrea S Foulkes; Muredach P Reilly Journal: J Am Coll Cardiol Date: 2013-05-30 Impact factor: 24.094
Authors: Daneyal Syed; Stephanie Peshenko; Kiang Liu; Ramon Durazo-Arvizu; Sylvia E Rosas; Michael Shlipak; Mark Sarnak; David Jacobs; David Sickovick; João Lima; Richard Kronmal; Holly Kramer Journal: J Integr Cardiol Date: 2018-05-22